Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
LUNGevity Foundation, a non-profit lung cancer organization, wants to learn about living with lung cancer from the point of view of people with lung cancer and their family and friends who provide care. To do this, we have an online study designed to better understand how treatments people living with lung cancer receive impact their quality of life. Participants will complete surveys once a month for 12 months. What does participation involve? 1. Emailing the study team to learn more and get access to the study website. 2. Once a month for 12 months you will receive a survey by email. 3. Complete these surveys on a smartphone, tablet, or computer at your convenience and receive an e-gift card for your time.
Checked against the public recordLast updated Apr 28, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- LUNGevity Foundation
- Interventions being studied
- Other: There are no interventions in this study. All participants complete online surveys.
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Adults with self-reported lung cancer diagnosis or caregiver of someone with a self-reported lung cancer diagnosis (patient has to be alive) * Ability to read and answer questions in English * Access and ability to use a computer or other internet-connected device Exclusion Criteria: * Younger than 18 * Healthcare providers and healthcare professionals who provide care to lung cancer patients except for those who are themselves a patient or a caregiver to a loved one. * Not able to provide informed consent
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- LUNGevity FoundationBethesda, Maryland
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 28, 2023. Always confirm current availability with the study team.